GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AnGes Inc (OTCPK:AMGXF) » Definitions » Cash Receipts from Operating Activities

AnGes (AMGXF) Cash Receipts from Operating Activities


View and export this data going back to 2014. Start your Free Trial

What is AnGes Cash Receipts from Operating Activities?

Cash Receipts from Operating Activities only applicable to companies reporting Cash Flow from Operations in direct method.


AnGes Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AnGes Inc (OTCPK:AMGXF) » Definitions » Cash Receipts from Operating Activities
Traded in Other Exchanges
Address
7-7-15, Saito-asagi, 4F, Saito Bio-Incubator, Ibaraki, Osaka, JPN, 567-0085
AnGes Inc is a biopharmaceutical company. The company's development projects include - HGF plasmid, NFkB decoy oligonucleotide, and Therapeutic vaccine.